These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 19578752)

  • 1. Small interference RNA-mediated suppression of overexpressed cyclin E protein restores G1/S regulation in NIH-OVCAR-3 ovarian cancer cells.
    Todd MC; Spruill SC; Meerbrey KL
    Int J Oncol; 2009 Aug; 35(2):375-80. PubMed ID: 19578752
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ovarian cancer cells that coexpress endogenous Rb and p16 are insensitive to overexpression of functional p16 protein.
    Todd MC; Sclafani RA; Langan TA
    Oncogene; 2000 Jan; 19(2):258-64. PubMed ID: 10645004
    [TBL] [Abstract][Full Text] [Related]  

  • 3. RhoA regulates G1-S progression of gastric cancer cells by modulation of multiple INK4 family tumor suppressors.
    Zhang S; Tang Q; Xu F; Xue Y; Zhen Z; Deng Y; Liu M; Chen J; Liu S; Qiu M; Liao Z; Li Z; Luo D; Shi F; Zheng Y; Bi F
    Mol Cancer Res; 2009 Apr; 7(4):570-80. PubMed ID: 19372585
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Overexpression of the low molecular weight cyclin E in transgenic mice induces metastatic mammary carcinomas through the disruption of the ARF-p53 pathway.
    Akli S; Van Pelt CS; Bui T; Multani AS; Chang S; Johnson D; Tucker S; Keyomarsi K
    Cancer Res; 2007 Aug; 67(15):7212-22. PubMed ID: 17671189
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Processing of cyclin E differs between normal and tumor breast cells.
    Harwell RM; Porter DC; Danes C; Keyomarsi K
    Cancer Res; 2000 Jan; 60(2):481-9. PubMed ID: 10667604
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phospholipase C delta 1 regulates cell proliferation and cell-cycle progression from G1- to S-phase by control of cyclin E-CDK2 activity.
    Kaproth-Joslin KA; Li X; Reks SE; Kelley GG
    Biochem J; 2008 Nov; 415(3):439-48. PubMed ID: 18588506
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The P16/cyclin D1/Rb pathway in neuroendocrine tumors of the lung.
    Beasley MB; Lantuejoul S; Abbondanzo S; Chu WS; Hasleton PS; Travis WD; Brambilla E
    Hum Pathol; 2003 Feb; 34(2):136-42. PubMed ID: 12612881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cell cycle genes as targets of retinoid induced ovarian tumor cell growth suppression.
    Zhang D; Vuocolo S; Masciullo V; Sava T; Giordano A; Soprano DR; Soprano KJ
    Oncogene; 2001 Nov; 20(55):7935-44. PubMed ID: 11753676
    [TBL] [Abstract][Full Text] [Related]  

  • 9. TSG101 expression in gynecological tumors: relationship to cyclin D1, cyclin E, p53 and p16 proteins.
    Bennett NA; Pattillo RA; Lin RS; Hsieh CY; Murphy T; Lyn D
    Cell Mol Biol (Noisy-le-grand); 2001 Nov; 47(7):1187-93. PubMed ID: 11838966
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Induction of senescence by progesterone receptor-B activation in response to cAMP in ovarian cancer cells.
    Takahashi A; Kato K; Kuboyama A; Inoue T; Tanaka Y; Kuhara A; Kinoshita K; Takeda S; Wake N
    Gynecol Oncol; 2009 May; 113(2):270-6. PubMed ID: 19211137
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Down-regulation of the HGF/MET autocrine loop induced by celecoxib and mediated by P-gp in MDR-positive human hepatocellular carcinoma cell line.
    Mazzanti R; Platini F; Bottini C; Fantappiè O; Solazzo M; Tessitore L
    Biochem Pharmacol; 2009 Jul; 78(1):21-32. PubMed ID: 19447220
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Loss of 9p leads to p16INK4A down-regulation and enables RB/E2F1-dependent cell cycle promotion in gastrointestinal stromal tumours (GISTs).
    Haller F; Löbke C; Ruschhaupt M; Cameron S; Schulten HJ; Schwager S; von Heydebreck A; Gunawan B; Langer C; Ramadori G; Sültmann H; Poustka A; Korf U; Füzesi L
    J Pathol; 2008 Jul; 215(3):253-62. PubMed ID: 18438954
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Growth suppression of human ovarian cancer cell lines by the introduction of a p16 gene via a recombinant adenovirus.
    Wolf JK; Kim TE; Fightmaster D; Bodurka D; Gershenson DM; Mills G; Wharton JT
    Gynecol Oncol; 1999 Apr; 73(1):27-34. PubMed ID: 10094876
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Silencing expression of UO-44 (CUZD1) using small interfering RNA sensitizes human ovarian cancer cells to cisplatin in vitro.
    Leong CT; Ong CK; Tay SK; Huynh H
    Oncogene; 2007 Feb; 26(6):870-80. PubMed ID: 16862170
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cell cycle dysregulation influences survival in high risk breast cancer patients.
    Königsberg R; Rögelsperger O; Jäger W; Thalhammer T; Klimpfinger M; De Santis M; Hudec M; Dittrich C
    Cancer Invest; 2008 Aug; 26(7):734-40. PubMed ID: 18665474
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of cyclins A, E and topoisomerase II alpha correlates with centrosome amplification and genomic instability and influences the reliability of cytometric S-phase determination.
    Kronenwett U; Castro J; Roblick UJ; Fujioka K; Ostring C; Faridmoghaddam F; Laytragoon-Lewin N; Tribukait B; Auer G
    BMC Cell Biol; 2003 Jul; 4():8. PubMed ID: 12875657
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improvement of sensitivity to platinum compound with siRNA knockdown of upregulated genes in platinum complex-resistant ovarian cancer cells in vitro.
    Yanagie H; Hisa T; Ogata A; Miyazaki A; Nonaka Y; Nishihira T; Osada I; Sairennji T; Sugiyama H; Furuya Y; Kidani Y; Takamoto S; Takahashi H; Eriguchi M
    Biomed Pharmacother; 2009 Sep; 63(8):553-60. PubMed ID: 18571892
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of low molecular weight derivatives of cyclin E1 is a function of cyclin E1 protein levels in breast cancer.
    Spruck C; Sun D; Fiegl H; Marth C; Mueller-Holzner E; Goebel G; Widschwendter M; Reed SI
    Cancer Res; 2006 Jul; 66(14):7355-60. PubMed ID: 16849587
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Regulation of the G1/S phase of the cell cycle and alterations in the RB pathway in human lung cancer.
    Wikman H; Kettunen E
    Expert Rev Anticancer Ther; 2006 Apr; 6(4):515-30. PubMed ID: 16613540
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Age differences in cyclin-dependent kinase inhibitor expression and rb hyperphosphorylation in human corneal endothelial cells.
    Enomoto K; Mimura T; Harris DL; Joyce NC
    Invest Ophthalmol Vis Sci; 2006 Oct; 47(10):4330-40. PubMed ID: 17003423
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.